H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Trading Down 0.0%
The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15. The stock has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The stock has a 50-day moving average price of $22.00 and a two-hundred day moving average price of $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.
Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
